Singapore, Singapore

Iolanda Micco

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Iolanda Micco: Innovator in Pharmaceutical Research

Introduction

Iolanda Micco is a prominent inventor based in Singapore, known for her contributions to pharmaceutical research. She has been instrumental in developing innovative solutions aimed at treating complex diseases, particularly Alzheimer's disease. With a total of 2 patents to her name, her work continues to impact the medical field significantly.

Latest Patents

Iolanda's latest patents focus on S1P3 antagonists. The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, specifically for the treatment of Alzheimer's disease. This groundbreaking work highlights her commitment to addressing critical health challenges.

Career Highlights

Iolanda Micco is currently associated with Teva Pharmaceutical Industries Limited, where she applies her expertise in pharmaceutical development. Her role involves extensive research and collaboration with other professionals in the field, contributing to the advancement of medical treatments.

Collaborations

Some of her notable coworkers include Chiara Caramelli and Cesare Federico. Their collective efforts in research and development have fostered an environment of innovation and creativity within the company.

Conclusion

Iolanda Micco's contributions to pharmaceutical research, particularly in the development of S1P3 antagonists, underscore her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds the potential to improve the lives of many individuals affected by Alzheimer's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…